Cas:7065-46-5 t-butylacetyl chloride manufacturer & supplier

We serve Chemical Name:t-butylacetyl chloride CAS:7065-46-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

t-butylacetyl chloride

Chemical Name:t-butylacetyl chloride
CAS.NO:7065-46-5
Synonyms:t-butylacetyl chloride;MFCD00000737;3,3-Dimethylbutanoyl chloride;Butanoyl chloride, 3,3-dimethyl-;EINECS 230-356-4;tert-Butylacetyl chloride
Molecular Formula:C6H11ClO
Molecular Weight:134.604
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:131.8±8.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.423
PSA:17.07000
Exact Mass:134.049850
LogP:2.22

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2924 3/PG 2
Packing Group:II


Contact us for information like t-butylacetyl chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tert-Butylacetyl chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,3-Dimethylbutanoyl chloride Use and application,tert-Butylacetyl chloride technical grade,usp/ep/jp grade.


Related News: Lilly has denied retaliating against any employees, and no lawsuit has been filed on behalf of Mula. t-butylacetyl chloride manufacturer Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. t-butylacetyl chloride supplier Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors. t-butylacetyl chloride vendor On April 8, a group of employees filed an anonymous complaint internally alleging that an executive at its Branchburg, New Jersey, factory had altered documents required by the U.S. Food and Drug Administration. t-butylacetyl chloride factory Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors.